Carson Allaria Wealth Management, Ltd. Dynavax Technologies Corp Transaction History
Carson Allaria Wealth Management, Ltd.
- $169 Million
- Q3 2024
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 565 shares of DVAX stock, worth $7,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
565
Previous 565
-0.0%
Holding current value
$7,186
Previous $6,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DVAX
# of Institutions
275Shares Held
130MCall Options Held
451KPut Options Held
203K-
Black Rock Inc. New York, NY21.9MShares$279 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$159 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$117 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$106 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$97.8 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.61B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...